Amphastar Pharmaceuticals
AMPH
#5798
Rank
HK$9.43 B
Marketcap
HK$221.26
Share price
0.41%
Change (1 day)
12.01%
Change (1 year)

EPS for Amphastar Pharmaceuticals (AMPH)

EPS in 2026 (TTM): HK$13.59

According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$13.64. In 2025 the company made an earnings per share (EPS) of HK$16.46 a decrease over its 2024 EPS that were of HK$25.79.

EPS history for Amphastar Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$13.59-17.45%
2025HK$16.46-36.17%
2024HK$25.7915.85%
2023HK$22.2651.87%
2022HK$14.6643.85%
2021HK$10.193521.88%
2020HK$0.28-96.55%
2019HK$8.15-900%
2018-HK$1.02-238.6%
2017HK$0.74-60.92%
2016HK$1.88
2014-HK$1.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tonix Pharmaceuticals
TNXP
-HK$101.44-843.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-HK$40.76-398.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
-HK$18.34-234.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-HK$30.34-322.41%๐Ÿ‡บ๐Ÿ‡ธ USA